BSX Financial Facts
Cost of products sold: 594MAmortization expense: 136M
See Full Income Statement
See Full Balance Sheet
Boston Scientific (BSX) Earnings
|
Expand Research on BSX
Next EPS Date | 4/24/24 | EPS Growth Rate | +8.5% |
---|---|---|---|
Average EPS % Beat Rate | +7.4% | Revenue Growth Rate | +8.6% |
Average % Move 1-Wk after EPS | +2.2% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
4/24/24 | Q124 | N/A | $0.51 | N/A | N/A | $3.68B | N/A | N/A | N/A | ||
1/31/24 | Q423 | $0.55 | $0.51 | +$0.04 | $3.73B | $3.6B | N/A | Details | |||
10/26/23 | Q323 | $0.50 | $0.48 | +$0.02 | $3.53B | $3.48B | = | Details | |||
7/27/23 | Q223 | $0.53 | $0.49 | +$0.04 | $3.6B | $3.5B | Details | ||||
4/26/23 | Q123 | $0.47 | $0.43 | +$0.04 | $3.39B | $3.16B | Details | ||||
2/1/23 | Q422 | $0.45 | $0.47 | -$0.02 | $3.24B | $3.24B | Details | ||||
10/26/22 | Q322 | $0.43 | $0.44 | -$0.01 | $3.17B | $3.15B | Details | ||||
7/27/22 | Q222 | $0.44 | $0.42 | +$0.02 | $3.24B | $3.21B | Details |